Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to -$54000.0.

  • GoHealth's Change in Accured Expenses rose 9703.13% to -$54000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 34806.74%. This contributed to the annual value of $27.6 million for FY2024, which is 1602.67% down from last year.
  • As of Q3 2025, GoHealth's Change in Accured Expenses stood at -$54000.0, which was up 9703.13% from -$21.2 million recorded in Q2 2025.
  • GoHealth's Change in Accured Expenses' 5-year high stood at $71.9 million during Q4 2024, with a 5-year trough of -$39.1 million in Q1 2025.
  • Over the past 5 years, GoHealth's median Change in Accured Expenses value was -$920000.0 (recorded in 2022), while the average stood at $1.8 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 224904.21% in 2022, then surged by 208817.28% in 2023.
  • Over the past 5 years, GoHealth's Change in Accured Expenses (Quarter) stood at $20.1 million in 2021, then surged by 41.14% to $28.3 million in 2022, then surged by 39.91% to $39.6 million in 2023, then soared by 81.51% to $71.9 million in 2024, then tumbled by 100.08% to -$54000.0 in 2025.
  • Its Change in Accured Expenses stands at -$54000.0 for Q3 2025, versus -$21.2 million for Q2 2025 and -$39.1 million for Q1 2025.